Sponsors (23)
Official title: To direct the Secretary of Veterans Affairs to establish a Blast Overpressure Task Force.
Introduced December 4, 2025 by Ronny Jackson · Last progress December 4, 2025
The bill improves diagnosis, treatment, and claims consistency for veterans with blast exposure through coordinated VA–DoD research and evidence-based guidance, but it requires federal resources, may raise long-term benefit costs, and provides only temporary oversight unless extended.
Veterans and active service members with blast exposure will receive better-tailored clinical care and benefits decisions because VA and DoD will coordinate research and clinical guidance.
Veterans filing claims will benefit from more standardized, evidence-based recommendations for claims processors and examiners, likely speeding decisions and reducing inconsistent outcomes.
Patients with chronic blast-related conditions (including many veterans) stand to gain faster development of diagnostics and treatments because the bill prioritizes translational research areas (sleep therapy, gut health, mobile diagnostics, vestibular/autonomic dysfunction, neuroinflammation, cumulative mTBI).
Veterans and taxpayers could face increased VA benefit expenditures if evidence-based recommendations lead to broader or higher-value awards without matching new funding.
Veterans and service members may lose sustained oversight or momentum on blast-related research and care because the temporary Task Force is set to sunset in 2029.
Taxpayers and federal employees will bear administrative and coordination costs to establish and run the temporary Task Force and associated research activities.
Based on analysis of 2 sections of legislative text.
Creates a VA–DoD Blast Overpressure Task Force to coordinate research, diagnostics, clinical care, and benefits-evaluation recommendations for blast-exposed service members and veterans.
Establishes a Blast Overpressure Task Force within the Department of Veterans Affairs, operating through the VA-DoD Joint Executive Committee, to coordinate research, clinical practice, diagnostics, and benefits evaluation for veterans and service members exposed to blast overpressure. The Task Force must be created within 180 days, prioritize translational research areas (including sleep therapy, gut health, mobile diagnostics, vestibular dysfunction, autonomic dysregulation, cumulative mild TBI, and neuroinflammation), integrate mobile and longitudinal diagnostic tools, monitor sensory and stress-related impairments, and submit annual reports with clinical and claims-evaluation recommendations. The Task Force will provide annual reports to the House and Senate Committees on Veterans’ Affairs and Armed Services, and it sunsets on September 30, 2029.